Similar articles for PMID: 35478154

Year	Number of Results
1993	1
1994	1
1995	1
1996	1
1997	1
1998	3
1999	4
2000	1
2002	2
2003	2
2004	4
2005	4
2006	3
2007	1
2008	3
2009	4
2010	5
2011	2
2012	11
2013	8
2014	7
2015	10
2016	6
2017	8
2018	10
2019	5
2020	6
2021	3
2022	3

1

Prognostic Factors of Survival After Radiotherapy for Lung Cancer-The Impact of Smoking Pack Years.

Werner EM, Glatzel E, Bohnet S, Schild SE, Rades D. Werner EM, et al. In Vivo. 2022 May-Jun;36(3):1297-1301. doi: 10.21873/invivo.12830. In Vivo. 2022. PMID: 35478154 Free PMC article.

2

Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB/IV nonsmall cell lung cancer.

Janjigian YY, McDonnell K, Kris MG, Shen R, Sima CS, Bach PB, Rizvi NA, Riely GJ. Janjigian YY, et al. Cancer. 2010 Feb 1;116(3):670-5. doi: 10.1002/cncr.24813. Cancer. 2010. PMID: 20029977 Free PMC article.

3

Prognostic impact of VEGF and VEGF receptor 1 (FLT1) expression in patients irradiated for stage II/III non-small cell lung cancer (NSCLC).

Rades D, Setter C, Dunst J, Dahl O, Schild SE, Noack F. Rades D, et al. Strahlenther Onkol. 2010 Jun;186(6):307-14. doi: 10.1007/s00066-010-2131-4. Epub 2010 Apr 26. Strahlenther Onkol. 2010. PMID: 20437013

4

Impact of cigarette smoking on response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutations.

Kim MH, Kim HR, Cho BC, Bae MK, Kim EY, Lee CY, Lee JS, Kang DR, Kim JH. Kim MH, et al. Lung Cancer. 2014 May;84(2):196-202. doi: 10.1016/j.lungcan.2014.01.022. Epub 2014 Feb 3. Lung Cancer. 2014. PMID: 24629638

5

Fibroblast growth factor 2--a predictor of outcome for patients irradiated for stage II-III non-small-cell lung cancer.

Rades D, Setter C, Dahl O, Schild SE, Noack F. Rades D, et al. Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):442-7. doi: 10.1016/j.ijrobp.2010.08.048. Epub 2010 Oct 14. Int J Radiat Oncol Biol Phys. 2012. PMID: 20950963

6

Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience.

Sibley GS, Jamieson TA, Marks LB, Anscher MS, Prosnitz LR. Sibley GS, et al. Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):149-54. doi: 10.1016/s0360-3016(97)00589-0. Int J Radiat Oncol Biol Phys. 1998. PMID: 9422571

7

Histology and smoking status predict survival of patients with advanced non-small-cell lung cancer. Results of West Japan Oncology Group (WJOG) Study 3906L.

Kogure Y, Ando M, Saka H, Chiba Y, Yamamoto N, Asami K, Hirashima T, Seto T, Nagase S, Otsuka K, Yanagihara K, Takeda K, Okamoto I, Aoki T, Takayama K, Yamasaki M, Kudoh S, Katakami N, Miyazaki M, Nakagawa K. Kogure Y, et al. J Thorac Oncol. 2013 Jun;8(6):753-8. doi: 10.1097/JTO.0b013e31828b51f5. J Thorac Oncol. 2013. PMID: 23575412 Free article.

8

Effectiveness of accelerated radiotherapy for patients with inoperable non-small cell lung cancer (NSCLC) and borderline prognostic factors without distant metastasis: a retrospective review.

Nguyen LN, Komaki R, Allen P, Schea RA, Milas L. Nguyen LN, et al. Int J Radiat Oncol Biol Phys. 1999 Jul 15;44(5):1053-6. doi: 10.1016/s0360-3016(99)00130-3. Int J Radiat Oncol Biol Phys. 1999. PMID: 10421538

9

Neutrophil-to-Lymphocyte Ratio Predicts Outcome in Limited Disease Small-cell Lung Cancer.

Käsmann L, Bolm L, Schild SE, Janssen S, Rades D. Käsmann L, et al. Lung. 2017 Apr;195(2):217-224. doi: 10.1007/s00408-017-9976-6. Epub 2017 Feb 2. Lung. 2017. PMID: 28154994

10

Results of high-dose thoracic irradiation incorporating beam's eye view display in non-small cell lung cancer: a retrospective multivariate analysis.

Hazuka MB, Turrisi AT 3rd, Lutz ST, Martel MK, Ten Haken RK, Strawderman M, Borema PL, Lichter AS. Hazuka MB, et al. Int J Radiat Oncol Biol Phys. 1993 Sep 30;27(2):273-84. doi: 10.1016/0360-3016(93)90238-q. Int J Radiat Oncol Biol Phys. 1993. PMID: 8407401

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed